Hefei Lifeon Pharmaceutical Co., Ltd.(XSEC:003020) added to S&P Global BMI Index
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.98 CNY | +2.29% | -0.02% | -10.56% |
05-21 | Lifeon Pharmaceutical's Unit Gets Marketing Authorization for Loxoprofen Sodium Oral Solution | MT |
05-15 | Hefei Lifeon Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.56% | 555M | |
+41.93% | 739B | |
+32.86% | 598B | |
-5.73% | 353B | |
+16.91% | 318B | |
+3.59% | 285B | |
+16.47% | 240B | |
+9.91% | 210B | |
-5.19% | 206B | |
+6.76% | 164B |
- Stock Market
- Equities
- 003020 Stock
- News Hefei Lifeon Pharmaceutical Co., Ltd.
- Hefei Lifeon Pharmaceutical Co., Ltd.(XSEC: 003020) added to S&P Global BMI Index